EcoDrugPlus

40s Ribosomal Protein S10-Like

Ensembl ID : ENSOTSG00005041555
Gene Symbol: LOC112254184
3 Cross references
363 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSOTSG00005013672
Gene Symbol: LOC112229034
3 Cross references
45 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSOTSG00005004853
Gene Symbol: LOC112229034
3 Cross references
183 Possible Orthologues:

40s Ribosomal Protein S16

Ensembl ID : ENSOTSG00005004561
Gene Symbol: LOC112267833
3 Cross references
306 Possible Orthologues:

40s Ribosomal Protein S24

Ensembl ID : ENSOTSG00005031256
Gene Symbol: LOC112253163
3 Cross references
482 Possible Orthologues:

40s Ribosomal Protein S24

Ensembl ID : ENSOTSG00005017898
Gene Symbol: LOC112253163
3 Cross references
482 Possible Orthologues:

40s Ribosomal Protein S24

Ensembl ID : ENSOTSG00005035342
Gene Symbol: LOC112253163
3 Cross references
482 Possible Orthologues:

40s Ribosomal Protein S28

Ensembl ID : ENSOTSG00005025235
Gene Symbol: LOC112244617
3 Cross references
273 Possible Orthologues:

40s Ribosomal Protein S28

Ensembl ID : ENSOTSG00005029979
Gene Symbol: LOC112244617
3 Cross references
273 Possible Orthologues:

40s Ribosomal Protein S3a

Ensembl ID : ENSOTSG00005015074
Gene Symbol: LOC112261300
3 Cross references
357 Possible Orthologues:

40s Ribosomal Protein S4-Like

Ensembl ID : ENSOTSG00005010994
Gene Symbol: LOC112259724
3 Cross references
488 Possible Orthologues:

40s Ribosomal Protein S9

Ensembl ID : ENSOTSG00005000964
Gene Symbol: LOC112225771
3 Cross references
231 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).